3
Metas de Enfermería

Metas de Enfermería

JULIO 2013 N° 6 Volumen 16

Efficacy of nursing intervention in treatment compliance for type 2 diabetic patients

Section: Cover story

How to quote

Lozano Del Hoyo ML, Armalé Casado MJ, Martes López C, Risco Otaolaurruchi MC, Martinez Menjón C, Bescos Pérez C. Eficacia de la intervención enfermera en la adherencia al tratamiento en pacientes diabéticos tipo 2. Metas Enferm 2013; 16(6):21-26.

Authors

Mª Luisa Lozano Del Hoyo, José Armalé Casado, Carmen Martes López, María Concepción Risco Otaolaurruchi, Carmen Martinez Menjón, Carmen Bescos Pérez 

Position

Enfermeras del Centro de Salud “Las Fuentes Norte”. Zaragoza.

Contact address

Mª Luisa Lozano Del Hoyo. C/ Escultor Félix Burriel, 1, 3º A. 50008 Zaragoza.

Contact email: mllozano@salud.aragon.es

Abstract

Objective: to assess whether a clear intervention targeted at improving pharmacological treatment compliance (prescribed doses and
schedule) represents an improvement in their correct use and, consequently, an improvement in metabolic control (HbAc1 reduction) in patients with Type 2 Diabetes.
Method: Quasi-experimental before-and-after study of an outpatient intervention without control arm, during 2010-2011, with Type 2 diabetic patients from the services portfolio in the “Las Fuentes Norte” Public Health Centre, Zaragoza, with pharmacological treatment and
follow-up by the Nursing Unit. In order to assess treatment compliance by patients, direct methods such as basal glycemic and HbAc1 control were used, as well as indirect methods, such as structured interviews, based on a survey by consensus with investigators.
Results: 232 patients were studied, with a 50-50% split between male and female, and 56% of which were over 70-year-old. Before the intervention, 55.2% of patients had glycemia > 140 mg/dl; 45.7% had HbAc1 > 7%; 22% had LDL-cholesterol > 130 mg/dl and only 25% had BMI <27; and 70-3% of patients had triglycerides < 150 mg/dl. There was a change from poor to good compliance in 10.9% (5) patients on insulin treatment, in 49.3% (106) of those patients taking oral antidiabetic drugs, and in 17.2% (25) of patients on treatment with hypolipemiant agents. The rest of patients showed good compliance, and this was sustained until the end of the study. In patients with improvement in treatment compliance, there was a significant reduction in HbAc1 (p ≤ 0.001) regardless of prescribed treatment.
Conclusions: to insist upon the fact that taking the prescribed drugs will lead to an improvement in metabolic control. Patients with low compliance must be identified, and strategies must be developed to help them to acknowledge their medications and dosing regimen, such as handing out a personalized sheet with dosing and administration schedules.

Keywords:

chronicity; complianceType 2 diabetes

Versión en Español

Título:

Eficacia de la intervención enfermera en la adherencia al tratamiento en pacientes diabéticos tipo 2

Artículo completo no disponible en este idioma / Full article is not available in this language

Bibliography

  1. Encuesta Nacional de Salud en España 2011/2012. Madrid: Ministerio de Sanidad, Servicios Sociales e Igualdad; 2012. [En línea] [fecha de acceso: 13 de junio de 2013]. URL disponible en: http://www.msssi.gob.es/estadEstudios/estadisticas/encuestaNacional/encuesta2011.htm
  2. Oliva J, Lobo F, Molina B, Monereo S. Direct health costs of diabetic patients in Spain. Diabetes Care 2004; 27:2616-21.
  3. Haffener S, Lehto S, Ronnemaa T, Pyör al K, Laasko M. La mortalidad por enfermedad coronaria en sujetos con diabetes tipo 2 y en sujetos no diabéticos con y sin infarto de miocardio. N Engl J Med 1998; 339:229-234.
  4. Cramer JA. Systematic review of adherence with medication for Diabetes. Diabetes Care 2004; 27:1218-24.
  5. Hartz A, Kent S, Jmaes P, Xu Y, Kelly M, Daly J. Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract 2006; 74:227-232.
  6. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003. Available on line at the WHO library an Information Networks for Knowledge Database (WHOLIS).
  7. Rubin RR. Adherence to pharmocologic therapy in patients with tipe 2 diabetes mellitus. Am J Med 2005; 118(supl 5):27-24.
  8. Odegard PS, Gris SL. Barriers to medicatios adherence in poorly control diabetes mellitus diabetes educator 2008; 34:692-697.
  9. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay tipe 2 diabetes in people with impaired glucose tolerance: sistematic review and meta-analysis. BM 2007; 334:299.
  10. Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study. Diabetes Care 2007; 30:128-134.
  11. Group UPDS. Intensive blood-glucose control with sulphonylureas or complications in patients with tipe 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853.
  12. Bezie Y, Molina M, Hernández N, Batista R, Niang, Huet D. Therapeutic complicance: a prespective análisis of various factors involved in the adherence rate in tipe 2 diabetes. Diabetes Metab 2006; 32:611-616.
  13. Donnan PT, MacDonald TM, Morrist AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with diabetes: a retrospective cohort study 2002 Diabetes UK. Diabetes Medicine 2002; 19(4):279-284.
  14. Martin L. Repercusiones para la salud pública de la adherencia terapeútica deficiente. Rev Cubana Salud Pública 2006; 32(3). [En línea] [fecha de acceso: 13 de junio de 2013]. URL disponible en: http://bvs.sld.cu/revistas/spu/vol32_3_06/spu13306.htm
  15. Gigoux JF, Moya P. Adherencia al tratamiento farmacológico y relación con el control metabólico en pacientes con Diabetes Mellitus tipo 2. Rev Chil Salud Pública 2010; 14(2-3):238-270.
  16. Brian R, Heather P, MacDonald, Amit X, Garge MA. Elping patients follow prescribed treatment. Clinical applications. JAMA 2002; 288:2880-83.
  17. Lozano ML, Armale MJ, Risco C, Martes C, Martín JI. Pie diabético. Educación a profesionales de Enfermería. En: libro de ponencias XI Congreso de la Federación Española de Educadores en Diabetes FEAED. Valencia; 2004. p. 13.
  18. García Pérez AM, Leiva Fernández F, Martos Crespo F, García Ruiz AJ, Prados Torres D, Sánchez de la Cuesta y Alarcón F. ¿Cómo diagnosticar el cumplimiento terapéutico en atención primaria? Medicina de Familia (And) 2000; 1:13-19.
  19. American Diabetes Association. Executive summary: standards of medical care in diabetes-2011. Diabetes Care 2011; 34(Suppl):4-10.
  20. American Diabetes Association. Executive summary: standards of medical care in diabetes-2011. Diabetes Care 2011; 33(Suppl):4-10.
  21. DiMateo MR. Variation in patients adherence to medical recommendations: quantitative review of 50 years of research. Med Care 2004; 42:200-209.
  22. Krapek K, King K, Warren SS, George KG, Caputo DA, Mihelich K. Medication adherence and associated hemoglobin A1C in type 2 diabetes. Ann Pharacother 2004; 38:1357-62.
  23. De León AC, del Castillo Rodríguez JC, Domínguez Coello S, Rodríguez Pérez MC, Brito Díaz B, Borges Álamo C. Estilo de vida y adherencia al tratamiento de la población Canaria con diabetes mellitus tipo 2. Rev Esp Salud Pública 2009; 83:567-575.
  24. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: a systematic literature review. Manag Care Interface 2006; 19:31-41.
  25. Clark DO, Von K, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care 1995; 33:783-795.
  26. Stratton IM, Adler AI, W Neil HA, Matthews DR, Manley SE, Cull CA. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321:405-412.
  27. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. An J Manag Care 2008; 14:71-75.
  28. Piñeiro F, Gil VF, Donis M, Torres MT, Orozco D, Merino J. Factores implicados en el incumplimiento del tratamiento farmacológico de la diabetes no insulino dependiente. Aten Primaria 1997; 20:415-420.
  29. García MD, Orozco D, Gil VF, Carratalá C, Terol C, Merino J. Relación entre el grado de cumplimiento farmacológico y el control de pacientes con hipertensión arterial, diabetes o dislipemias. Med Clin 2001; 116:141-146.
  30. Fedrick F, Justin-Temu M. Factors contributing to non-adherence to diabetes treatment among diabetic patients attending clinic in Mwanza city. East Afr J Public Health 2012; 9(3):90-95.
  31. Tiv M, Viel JF, Mauny F, Eschwége E, Weil A, Fournier C, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PloS One 2012; 7(3):e32412.
  32. Parada HJr, Horton LA, Cherrington A, Ibarra L, Ayala GX. Correlates of medication nonadherence among latinos with tipe 2 diabetes. Diabetes Educ 2012; 38(4):552-561.
  33. Bailey GR, Barner JC, Weems JK, Leckbee G, Solis R, Montemayor D. Assessing barriers to medication adherence in underserved patients with diabetes in Texas. Diabetes Educ 2012; 38(2):271-279.
  34. Ross SA, Tildesley HD, Ashkenas J. Barriers to effective insulin treatmen: the persistence of poor glycemic control in type 2 diabetes. Curr Med Res Opin 2011; 27(Suppl 3):13-20.
  35. Moreau A, Aroles V, Souweine G, Flori M, Erpeldinger S, Figon S, et al. Patient versus general practitioner perception of problems with treatment adherence in type 2 diabetes: from adherence to concordance. Eur J Gen Pract 2009; 15(3):147-153.
  36. Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract 2011; 65(3):314-322.
  37. Van-Dulmen S, Sluijs E, Van-Dijk L, De-Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 2007; 7:55.
  38. Hughes DA, Bagust A, Haycox A, Walley T. Accounting for noncompliance in farmacoeconomic avaluation. Pharmacoecnonomics 2001; 19:1185-97.
  39. Kalyango JN, Owino E, Nambuya AP. Non-adherence to diabetes tretment at Mulago Hospital in Uganga: prevalence and associated factors. Afr Health Sci 2008; 8(2):67-73.
  40. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005; 118(suppl.5A):27-34.